Trial Information

Summary: Anemia

This is a phase III open label randomized controlled study for women with low blood count due to heavy menstrual bleeding or postpartum patients. Patients will be randomly assigned to standard therapy (oral iron supplements or a single dose of study drug given through IV) The aim of the treatment is to see if a single dose can rebuild the iron vs. an oral supplement. The study will last approximately 6 weeks with 3 office visits. You will be compensated for your time and travel.

Patient Inclusion Criteria:

• Females with iron deficiency anemia
• Postpartum or have history of heavy uterine bleeding w/in the past 6 months

Patient Exclusion Criteria:

• GI bleed w/in the last 3 months
• Any anticipated need for a surgical procedure during study
• Active infection requiring antibiotics

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:37:41 AM